Uveal melanoma risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 12: Line 12:
**Iris nevi
**Iris nevi
:The risk of progression of iris nevi to melanoma at 5, 10, 15, and 20 years is 3, 4, 8, and 11 percent, respectively. Significant risks factors associated with an increased :risk of transformation include younger age, inferior location, diffuse pigmentation, presence of blood in the lesion, ectropion, and a feathery margin.<ref name="pmid23290981">{{cite journal| author=Shields CL, Kaliki S, Hutchinson A, Nickerson S, Patel J, Kancherla S et al.| title=Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide. | journal=Ophthalmology | year= 2013 | volume= 120 | issue= 4 | pages= 766-72 | pmid=23290981 | doi=10.1016/j.ophtha.2012.09.042 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23290981  }} </ref>
:The risk of progression of iris nevi to melanoma at 5, 10, 15, and 20 years is 3, 4, 8, and 11 percent, respectively. Significant risks factors associated with an increased :risk of transformation include younger age, inferior location, diffuse pigmentation, presence of blood in the lesion, ectropion, and a feathery margin.<ref name="pmid23290981">{{cite journal| author=Shields CL, Kaliki S, Hutchinson A, Nickerson S, Patel J, Kancherla S et al.| title=Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide. | journal=Ophthalmology | year= 2013 | volume= 120 | issue= 4 | pages= 766-72 | pmid=23290981 | doi=10.1016/j.ophtha.2012.09.042 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23290981  }} </ref>
:**Choroidal nevi
:*Choroidal nevi
:Generally, choroidal melanoma arises in pigmented nevi. The risk of progression to melanoma at 5, 10, and 15 years is 9, 13, and 17 percent, respectively.<ref name="pmid19667334">{{cite journal| author=Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH et al.| title=Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. | journal=Arch Ophthalmol | year= 2009 | volume= 127 | issue= 8 | pages= 981-7 | pmid=19667334 | doi=10.1001/archophthalmol.2009.151 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19667334  }} </ref>
:Generally, choroidal melanoma arises in pigmented nevi. The risk of progression to melanoma at 5, 10, and 15 years is 9, 13, and 17 percent, respectively.<ref name="pmid19667334">{{cite journal| author=Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH et al.| title=Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. | journal=Arch Ophthalmol | year= 2009 | volume= 127 | issue= 8 | pages= 981-7 | pmid=19667334 | doi=10.1001/archophthalmol.2009.151 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19667334  }} </ref>
*Host pigmentation factors
*Host pigmentation factors

Revision as of 18:20, 24 October 2015

Uveal melanoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveal melanoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveal melanoma risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveal melanoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveal melanoma risk factors

CDC on Uveal melanoma risk factors

Uveal melanoma risk factors in the news

Blogs on Uveal melanoma risk factors

to Hospitals Treating Uveal melanoma

Risk calculators and risk factors for Uveal melanoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Common risk factors in the development of uveal melanoma are cutaneous and iris nevi, host pigmentation factors, and ultraviolet light exposure.

Risk Factors

Common risk factors in the development of uveal melanoma include:

  • Cutaneous and iris nevi
    • Atypical cutaneous nevi
    • Common cutaneous nevi
    • Cutaneous freckles
    • Iris nevi
The risk of progression of iris nevi to melanoma at 5, 10, 15, and 20 years is 3, 4, 8, and 11 percent, respectively. Significant risks factors associated with an increased :risk of transformation include younger age, inferior location, diffuse pigmentation, presence of blood in the lesion, ectropion, and a feathery margin.[1]
  • Choroidal nevi
Generally, choroidal melanoma arises in pigmented nevi. The risk of progression to melanoma at 5, 10, and 15 years is 9, 13, and 17 percent, respectively.[2]
  • Host pigmentation factors
    • Light eye color
    • Fair skin color
    • Propensity to sunburn
  • Ultraviolet light exposure

References

  1. Shields CL, Kaliki S, Hutchinson A, Nickerson S, Patel J, Kancherla S; et al. (2013). "Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide". Ophthalmology. 120 (4): 766–72. doi:10.1016/j.ophtha.2012.09.042. PMID 23290981.
  2. Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH; et al. (2009). "Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases". Arch Ophthalmol. 127 (8): 981–7. doi:10.1001/archophthalmol.2009.151. PMID 19667334.